KIORA PHARMACEUTICALS, INC. Increase Decrease In Operating Lease Liability
KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase Decrease In Operating Lease Liability of -$82.61 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$40.66K.
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$41.95K.
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$37.09K.
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$27.96K.
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2025 was -$103.84K.
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2024 was -$46.50K, a 8062.33% decline from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2023 was $584.00.
- KIORA PHARMACEUTICALS, INC. increase decrease in operating lease liability for fiscal 2022 was -$103.63K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$40.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$82.61K 10-Q · filed 2026-08-07 | -$119.71K derived: sum of 3 quarters · filed 2026-08-07 | -$147.67K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$41.95K 10-Q · filed 2026-05-08 | -$79.05K derived: sum of 2 quarters · filed 2026-05-08 | -$107.01K derived: sum of 3 quarters · filed 2026-05-08 | -$133.45K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$37.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$65.06K derived: sum of 2 quarters · filed 2026-03-25 | -$91.50K derived: sum of 3 quarters · filed 2026-08-07 | -$103.84K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$27.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$54.40K derived: sum of 2 quarters · filed 2026-08-07 | -$66.75K 10-Q · filed 2025-11-07 | -$78.22K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$26.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$38.78K 10-Q · filed 2026-08-07 | -$50.26K derived: sum of 3 quarters · filed 2026-08-07 | -$62.39K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$12.35K 10-Q · filed 2026-05-08 | -$23.82K derived: sum of 2 quarters · filed 2026-05-08 | -$35.96K derived: sum of 3 quarters · filed 2026-05-08 | -$47.51K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$11.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$23.61K derived: sum of 2 quarters · filed 2026-03-25 | -$35.16K derived: sum of 3 quarters · filed 2026-03-25 | -$46.50K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$12.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$23.68K derived: sum of 2 quarters · filed 2025-11-07 | -$35.03K 10-Q · filed 2025-11-07 | $52.42K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$11.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$22.89K 10-Q · filed 2025-08-08 | $64.56K derived: sum of 3 quarters · filed 2025-08-08 | $44.69K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$11.34K 10-Q · filed 2025-05-09 | $76.10K derived: sum of 2 quarters · filed 2025-05-09 | $56.24K derived: sum of 3 quarters · filed 2025-05-09 | $22.02K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $87.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $67.58K derived: sum of 2 quarters · filed 2025-03-25 | $33.36K derived: sum of 3 quarters · filed 2025-03-25 | $584.00 10-K · filed 2025-03-25 |
| 2023-09-30 | -$19.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$54.08K derived: sum of 2 quarters · filed 2024-11-08 | -$86.86K 10-Q · filed 2024-11-08 | -$65.71K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$34.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$67.00K 10-Q · filed 2024-08-09 | -$45.84K derived: sum of 3 quarters · filed 2024-08-09 | -$73.95K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$32.78K 10-Q · filed 2024-05-10 | -$11.62K derived: sum of 2 quarters · filed 2024-05-10 | -$39.73K derived: sum of 3 quarters · filed 2024-05-10 | -$85.31K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $21.16K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$6.95K derived: sum of 2 quarters · filed 2024-03-25 | -$52.53K derived: sum of 3 quarters · filed 2024-03-25 | -$103.63K 10-K · filed 2024-03-25 |
| 2022-09-30 | -$28.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$73.68K derived: sum of 2 quarters · filed 2023-11-09 | -$124.78K 10-Q · filed 2023-11-09 | -$173.25K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$45.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$96.68K 10-Q · filed 2023-08-08 | -$145.15K derived: sum of 3 quarters · filed 2023-08-08 | -$192.27K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$51.10K 10-Q · filed 2023-05-09 | -$99.56K derived: sum of 2 quarters · filed 2023-05-09 | -$146.69K derived: sum of 3 quarters · filed 2023-05-09 | -$193.59K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$48.46K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$95.59K derived: sum of 2 quarters · filed 2023-03-23 | -$142.49K derived: sum of 3 quarters · filed 2023-03-23 | -$181.98K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$47.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$94.02K derived: sum of 2 quarters · filed 2022-11-09 | -$133.51K 10-Q · filed 2022-11-09 | -$175.44K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$46.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$86.39K 10-Q · filed 2022-08-12 | -$128.31K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$39.49K 10-Q · filed 2022-07-08 | -$81.42K derived: sum of 2 quarters · filed 2022-07-08 | ||
| 2020-12-31 | -$41.93K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | -$166.82K 10-K/A · filed 2022-07-07 | ||
| 2020-09-30 | -$124.90K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |